Trial Profile
Response to salmeterol/fluticasone propionate in patients with COPD patients and different plasma surfactant protein D levels
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 02 Dec 2015 New trial record